Review of concepts in therapeutic decision-making in HER2-negative luminal metastatic breast cancer

Alvarez-Lopez, I; Bezares, S; Portulas, ED; Garcia-Martinez, E; Garcia-Saenz, JA; Gil-Gil, M; de Duenas, EM; Ribelles, N; Bertran, AS

Alvarez-Lopez, I (corresponding author), Hosp Univ Donostia BioDonostia, Begiristain Doktorea Pasealekua 109, Donostia San Sebastian 20014, Gipuzkoa, Spain.; Alvarez-Lopez, I (corresponding author), GEICAM Spanish Breast Canc Grp, Grp GEICAM Invest Canc Mama, Madrid, Spain.

CLINICAL & TRANSLATIONAL ONCOLOGY, 2020; 22 (8): 1364

Abstract

Purpose Hormone receptor (HR)-positive, Human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer (MBC) requires a therapeutic......

Full Text Link